AI assistant
Sending…
HAEMONETICS CORP — Director's Dealing 2014
May 22, 2014
31565_dirs_2014-05-22_981be3a0-7bcd-4078-9ab2-04fccf40ce5f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2014-05-12
Reporting Person: Davies Kent J (President, Global Markets)
More from HAEMONETICS CORP
Annual Report
2026
May 20
Major Shareholding Notification
2026
May 13
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 4
Regulatory Filings
2026
Mar 3
Major Shareholding Notification
2026
Feb 13